Humoral Immunosuppressive Substance in Mice Bearing Plasmacytomas
- 22 November 1974
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 186 (4165), 748-750
- https://doi.org/10.1126/science.186.4165.748
Abstract
The mechanism by which plasmacytomas (PC) depress the primary immune response to sheep red cells was investigated by determining the ability of normal spleen cells to produce antibody when enclosed in Millipore chambers and implanted in PC-bearing mice. Chamber-enclosed normal spleen cells implanted in PC-bearing mice responded poorly to the sheep red cells when compared to similar cells enclosed in chambers and implanted in normal mice or in mice with other lymphoid and nonlymphoid tumors. The data suggest that PC-induced immune suppression is mediated by a humoral factor.Keywords
This publication has 10 references indexed in Scilit:
- “PARANEOPLASTIC” SYNDROMES ASSOCIATED WITH MONOCLONAL LYMPHOCYTE AND PLASMA CELL PROLIFERATION*Annals of the New York Academy of Sciences, 1974
- Kinetics of tumor growth and regression in IgG multiple myelomaJournal of Clinical Investigation, 1972
- The Cell Site of the Immunological Defect in Tumor-Bearing MiceExperimental Biology and Medicine, 1971
- The Effect of Tumour Growth on Immune CompetenceBritish Journal of Cancer, 1970
- Effect of Plasma Cell Tumor on Antibody Production by Mouse Spleen CellsExperimental Biology and Medicine, 1968
- Immune responses in preleukaemic and leukaemic AKR miceInternational Journal of Cancer, 1967
- Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma*Journal of Clinical Investigation, 1964
- Reduced Antibody Forming Capacity During the Incubation Period of Passage A Leukemia in C3H Mice.Experimental Biology and Medicine, 1963
- Antibody Quality after Sequential Immunization with Related AntigensScience, 1963
- QUANTITATIVE ANTIBODY STUDIES IN MAN. III. ANTIBODY RESPONSE IN LEUKEMIA AND OTHER MALIGNANT LYMPHOMATA 1Journal of Clinical Investigation, 1953